{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:13:28Z","timestamp":1787436808974,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010476","name":"Tata Memorial Centre","doi-asserted-by":"publisher","award":["637"],"award-info":[{"award-number":["637"]}],"id":[{"id":"10.13039\/501100010476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007179","name":"Advanced Centre for Treatment, Research and Education in Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007179","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.intimp.2023.110437","type":"journal-article","created":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T10:50:36Z","timestamp":1686480636000},"page":"110437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effect"],"prefix":"10.1016","volume":"121","author":[{"given":"Saurabh","family":"Kumar Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dievya","family":"Gohil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepshikha","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish Ch.","family":"Panigrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puja","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajal","family":"Dalvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Twinkle","family":"Khanka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Kumar Kaushal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akanksha","family":"Chichra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7461-4772","authenticated-orcid":false,"given":"Sachin","family":"Punatar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anant","family":"Gokarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeet","family":"Mirgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishant","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingaraj","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant R.","family":"Tembhare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Khizer Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Kumar Sandur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lal","family":"Hingorani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin","family":"Khattry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6348-6667","authenticated-orcid":false,"given":"Vikram","family":"Gota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2023.110437_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-2-35","article-title":"Acute graft versus host disease","volume":"2","author":"Jacobsohn","year":"2007","journal-title":"Orphanet J. Rare Dis."},{"issue":"22","key":"10.1016\/j.intimp.2023.110437_b0010","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute graft-versus-host disease \u2014 biologic process, prevention, and therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.intimp.2023.110437_b0015","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1182\/bloodadvances.2018020214","article-title":"GVHD: biology matters","volume":"2","author":"Ferrara","year":"2018","journal-title":"Blood Adv."},{"issue":"39","key":"10.1016\/j.intimp.2023.110437_b0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev-immunol-102119-073227","article-title":"Current concepts and advances in graft-versus-host disease immunology","volume":"26","author":"Hill","year":"2021","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110437_b0025","article-title":"Graft versus host disease: from basic pathogenic principles to DNA damage response and cellular senescence","volume":"2018","author":"Kuba","year":"2018","journal-title":"Mediators Inflamm."},{"issue":"21","key":"10.1016\/j.intimp.2023.110437_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20215310","article-title":"Withania somnifera (Ashwagandha) and withaferin a: potential in integrative oncology","volume":"20","author":"Dutta","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2023.110437_b0035","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.taap.2015.09.014","article-title":"Thiol dependent NF-\u03baB suppression and inhibition of T-cell mediated adaptive immune responses by a naturally occurring steroidal lactone Withaferin A","volume":"289","author":"Gambhir","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110437_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13048-020-00684-x","article-title":"Withaferin A: a potential therapeutic agent against COVID-19 infection","volume":"13","author":"Straughn","year":"2020","journal-title":"J. Ovarian Res."},{"issue":"5","key":"10.1016\/j.intimp.2023.110437_b0045","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10565-016-9340-2","article-title":"Assessment of hepatoprotective and nephroprotective potential of withaferin A on bromobenzene-induced injury in Swiss albino mice: possible involvement of mitochondrial dysfunction and inflammation","volume":"32","author":"Vedi","year":"2016","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.intimp.2023.110437_b0050","doi-asserted-by":"crossref","unstructured":"R. Das, A. Rauf, S. Akhter, M.N. Islam, E.T. Bin, Role of Withaferin A and its derivatives in the management of Alzheimer \u2019 s disease\u00a0: recent trends and future perspectives, 2021.","DOI":"10.3390\/molecules26123696"},{"issue":"3","key":"10.1016\/j.intimp.2023.110437_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17030290","article-title":"Withaferin-A\u2014a natural anticancer agent with pleitropic mechanisms of action","volume":"17","author":"Lee","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"FEB","key":"10.1016\/j.intimp.2023.110437_b0060","article-title":"Withaferin a associated differential regulation of inflammatory cytokines","volume":"9","author":"Dubey","year":"2018","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110437_b0065","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s00125-012-2813-9","article-title":"Withaferin A inhibits pro-inflammatory cytokine-induced damage to islets in culture and following transplantation","volume":"56","author":"Sorelle","year":"2013","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.intimp.2023.110437_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-90181-y","article-title":"Withaferin A inhibits lymphocyte proliferation, dendritic cell maturation in vitro and prolongs islet allograft survival","volume":"11","author":"Kumano","year":"2021","journal-title":"Sci. Rep."},{"issue":"April","key":"10.1016\/j.intimp.2023.110437_b0075","doi-asserted-by":"crossref","first-page":"106575","DOI":"10.1016\/j.intimp.2020.106575","article-title":"International Immunopharmacology Prevention of acute graft-versus-host-disease by Withaferin a via suppression of AKT \/ mTOR pathway","volume":"84","author":"Mehta","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2023.110437_b0080","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.3727\/096368912X653110","article-title":"Cytokine profiles in various graft-versus-host disease target organs following hematopoietic stem cell transplantation","volume":"21","author":"Lai","year":"2012","journal-title":"Cell Transplant."},{"issue":"8","key":"10.1016\/j.intimp.2023.110437_b0085","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1038\/s41375-019-0394-z","article-title":"The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells","volume":"33","author":"Zhang","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.intimp.2023.110437_b0090","doi-asserted-by":"crossref","unstructured":"Y. Chang, X. Zhao, X. Huang, Strategies for enhancing and preserving anti-leukemia effects without aggravating graft-versus-host disease 9 (December) (2018) 1\u201317.","DOI":"10.3389\/fimmu.2018.03041"},{"key":"10.1016\/j.intimp.2023.110437_b0095","doi-asserted-by":"crossref","unstructured":"K.R. Cooke, Jr JD, J.L. Ferrara, K.R. Cooke, G.R. Hill, J.M. Crawford, et al., Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. Find the latest version\u00a0: Tumor Necrosis Factor \u2013 Production to Lipopolysaccharide Stimulati. 102 (10) (1998) 1882\u20131891.","DOI":"10.1172\/JCI4285"},{"issue":"9","key":"10.1016\/j.intimp.2023.110437_b0100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fimmu.2018.00010","article-title":"Simple, reproducible, and efficient clinical grading system for murine models of acute graft-versus-host disease","volume":"22","author":"Naserian","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.110437_b0105","doi-asserted-by":"crossref","unstructured":"B.K.R. Cooke, L. Kobzik, T.R. Martin, J. Brewer, Jr JD, J.M. Crawford, et al., An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin, Blood 88 (8) (1996) 3230\u20133239.","DOI":"10.1182\/blood.V88.8.3230.bloodjournal8883230"},{"issue":"1","key":"10.1016\/j.intimp.2023.110437_b0110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/imcb.12504","article-title":"Comprehensive immune cell profiling depicts an early immune response associated with severe coronavirus disease 2019 in cancer patients","volume":"100","author":"Tembhare","year":"2022","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.intimp.2023.110437_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2015.05.011","article-title":"A nuclear factor-\u03baB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates GVHD in allogeneic bone marrow transplantation","author":"Yamanouchi","year":"2015","journal-title":"Immunobiology"},{"issue":"23","key":"10.1016\/j.intimp.2023.110437_b0120","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2023.110437_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-9255-6-15","article-title":"Inhibition of NFB by the natural product withaferin a in cellular models of cystic fibrosis inflammation","volume":"6","author":"Maitra","year":"2009","journal-title":"J. Inflamm."},{"issue":"6","key":"10.1016\/j.intimp.2023.110437_b0130","first-page":"259","article-title":"Vaccine against arteriosclerosis: an update","volume":"9","author":"Soiza","year":"2018","journal-title":"Ther Adv Vaccines."},{"key":"10.1016\/j.intimp.2023.110437_b0135","doi-asserted-by":"crossref","unstructured":"X. Hu, J. li, M. Fu, X. Zhao, W. Wang, The JAK\/STAT signaling pathway: from bench to clinic, Signal Transduct. Target Ther. 6 (1) (2021).","DOI":"10.1038\/s41392-021-00791-1"},{"key":"10.1016\/j.intimp.2023.110437_b0140","doi-asserted-by":"crossref","unstructured":"H.J. Um, K. jin Min, D.E. Kim, T.K. Kwon, Withaferin A inhibits JAK\/STAT3 signaling and induces apoptosis of human renal carcinoma Caki cells, Biochem. Biophys. Res. Commun. 427 (1) (2012) 24\u201329.","DOI":"10.1016\/j.bbrc.2012.08.133"},{"key":"10.1016\/j.intimp.2023.110437_b0145","doi-asserted-by":"crossref","first-page":"S18863","DOI":"10.4137\/BCI.S18863","article-title":"Withaferin A inhibits STAT3 and induces tumor cell death in neuroblastoma and multiple myeloma","volume":"7","author":"Yco","year":"2014","journal-title":"Biochem Insights."},{"key":"10.1016\/j.intimp.2023.110437_b0150","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev-immunol-042617-053119","article-title":"Nonclassical monocytes in health and disease","volume":"37","author":"Narasimhan","year":"2019","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110437_b0155","doi-asserted-by":"crossref","first-page":"102286","DOI":"10.1016\/j.isci.2021.102286","article-title":"Targeting SLP76: ITK interaction separates GVHD from GVL in allo-HSCT","volume":"24","author":"Mammadli","year":"2021","journal-title":"Iscience."},{"key":"10.1016\/j.intimp.2023.110437_b0160","doi-asserted-by":"crossref","unstructured":"T.V. Brennan, Y. Yang, T.V. Brennan, Y. Yang, PD-L1 serves as a double agent in separating GVL from GVHD PD-L1 serves as a double agent in separating GVL from GVHD, 127 (5) (2017) 1627\u20131630.","DOI":"10.1172\/JCI94196"},{"issue":"10","key":"10.1016\/j.intimp.2023.110437_b0165","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1182\/blood-2017-08-752162","article-title":"The potential role of gd T cells after allogeneic HCT for leukemia","volume":"131","author":"Handgretinger","year":"2018","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.intimp.2023.110437_b0170","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.bmt.1705650","article-title":"Long term disease-free survival in acute leukemia patients recovering with increased \u03b3\u03b4 T cells after partially mismatched related donor bone marrow transplantation","volume":"39","author":"Godder","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.intimp.2023.110437_b0175","doi-asserted-by":"crossref","unstructured":"M.S. Hossain, G.M. Kunter, V.F. El-najjar, D.L. Jaye, Al- Z, O.K. Taofeek, et al., PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo- HSCT recipients (2017) 1\u201319.","DOI":"10.1371\/journal.pone.0184254"},{"issue":"7","key":"10.1016\/j.intimp.2023.110437_b0180","doi-asserted-by":"crossref","first-page":"42817","DOI":"10.4049\/jimmunol.177.7.4281","article-title":"Preferential involvement of Tim-3 in the regulation of hepatic CD8+ T cells in murine acute graft-versus-host disease","volume":"177","author":"Oikawa","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.110437_b0185","first-page":"20","article-title":"TIM3 comes of age as an inhibitory receptor","author":"Wolf","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110437_b0190","first-page":"228","article-title":"Current approaches to prevent and treat GVHD after allogeneic stem cell transplantation","volume":"2018","author":"Hamilton","year":"2018","journal-title":"Hematol (United States)."},{"issue":"8","key":"10.1016\/j.intimp.2023.110437_b0195","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbmt.2009.04.004","article-title":"Graft-versus-host disease prophylaxis with tacrolimus and mycophenolate Mofetil in HLA-matched nonmyeloablative transplant recipients is associated with very low incidence of GVHD and nonrelapse mortality","volume":"15","author":"Sabry","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.intimp.2023.110437_b0200","unstructured":"J. Long, L. Chang, Y. Shen, W. Gao, Y. Wu, H. Dou, et al., Valproic Acid Ameliorates Graft-versus-Host Disease by Downregulating Th1 and Th17 Cells, 2022."},{"key":"10.1016\/j.intimp.2023.110437_b0205","doi-asserted-by":"crossref","unstructured":"H. Rafei, E. Elbahesh, Acute graft versus host disease\u00a0: a comprehensive review, 1555 (2017) 1547\u20131555.","DOI":"10.21873\/anticanres.11483"},{"issue":"May","key":"10.1016\/j.intimp.2023.110437_b0210","first-page":"1204","article-title":"Safety, toxicity and pharmacokinetic assessment of oral Withaferin-A in mice","volume":"9","author":"Kumar","year":"2022","journal-title":"Toxicol Reports."},{"issue":"1","key":"10.1016\/j.intimp.2023.110437_b0215","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaim.2018.12.008","article-title":"Safety and pharmacokinetics of Withaferin-A in advanced stage high grade osteosarcoma: A phase I trial","volume":"11","author":"Pires","year":"2020","journal-title":"J. Ayurveda Integr. Med."},{"issue":"1","key":"10.1016\/j.intimp.2023.110437_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.20190418","article-title":"Biology and therapeutic potential of interleukin-10","volume":"217","author":"Saraiva","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2023.110437_b0225","doi-asserted-by":"crossref","unstructured":"E.H. Steen, X. Wang, S. Balaji, M.J. Butte, P.L. Bollyky, S.G. Keswani, The role of the anti-inflammatory cytokine interleukin-10 in tissue fibrosis, 9 (4) (2020) 184\u2013198.","DOI":"10.1089\/wound.2019.1032"},{"key":"10.1016\/j.intimp.2023.110437_b0230","article-title":"Cytokine storm release syndrome and the prospects for immunotherapy with COVID-19, part 4: The role of JAK inhibition","volume":"1\u20136","author":"Calabrese","year":"2020","journal-title":"Cleve. Clin. J. Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923007609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923007609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:09:59Z","timestamp":1761588599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923007609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":46,"alternative-id":["S1567576923007609"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110437","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effect","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110437"}}